Cerebral imaging changes in patients with chronic renal failure treated conservatively or in hemodialysis
- PMID: 11528229
- DOI: 10.1159/000046040
Cerebral imaging changes in patients with chronic renal failure treated conservatively or in hemodialysis
Abstract
Background: Nonuremic patients with apparently normal memory and behavior, studied by means of cerebral computed tomography and found to have cerebral atrophy (CA), evidenced functional intellectual deficits when they underwent psychometric testing. The finding of CA has been repeatedly reported in limited case groups of uremic patients who also demonstrated functional intellectual deficits on the basis of the same tests. This retrospective study considered all diagnostic cerebral computed tomography scans done in our department between 1981 and 1998. Fifty-five uremic patients in conservative treatment (CT) and 111 patients in hemodialysis treatment (HT) were selected on the basis of the following two criteria: primary nephropathy as the cause of uremia and an age < or =55 years to exclude involutive brain changes occurring with age.
Aims: The aims of the study were to determine the percent of uremic patients with CA, the characteristics of their CA (cortical or subcortical), and eventual associated morphological lesions.
Results: CA was detected in 50.9% (cortical atrophy in 47.3% and subcortical atrophy in 3.6%) of the uremic patients in CT and in 77.5% of those in HT (cortical atrophy in 65.7% and subcortical atrophy in 7.7%). The average degree of CA was 0.872 in the patients in CT and 1.765 in the patients in HT. Thirty-four of the patients in the CT group and 46 in the HT group were hypertensive: these patients had a more severe degree of CA than the nonhypertensive subjects. In the CT group, the degree of CA in the hypertensive patients was 1.205 versus 0.428 for the nonhypertensive subjects. In the HT group, the degree of CA was 2.087 for the hypertensive patients versus 1.538 for the nonhypertensive patients. Of the overall population, 7.8% had ischemic lesions, 9.6% had endocranial calcifications, and 5.4% evidenced periventricular white matter hyperintensities.
Conclusions: The high percent of CA found in young uremic patients increased in subjects in HT and, even more so in hypertensive patients. Vascular calcifications, focal ischemia and leukoaraiosis, well-known expressions of a chronic state of cerebrovascular insufficiency, were also found in HT patients; hypertension alone is a recognized accelerator of vascular damage. Thus, early and severe atherosclerosis and related hypoperfusion can be considered as the paramount causes of parenchymal cerebral damage in uremia.
Copyright 2001 S. Karger AG, Basel
Comment in
-
Brain atrophy in uremia: its underevaluated meaning and consequences.Nephron. 2002 Apr;90(4):510. doi: 10.1159/000054746. Nephron. 2002. PMID: 11961417 No abstract available.
Similar articles
-
Hypertension as an etiopathological factor in the development of cerebral atrophy in hemodialyzed patients.Nephron. 1999 Jan;81(1):17-24. doi: 10.1159/000045240. Nephron. 1999. PMID: 9884414 Clinical Trial.
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
-
Diastolic blood pressure is associated with brain atrophy in hemodialysis patients: A single center case-control study.Ther Apher Dial. 2022 Feb;26(1):94-102. doi: 10.1111/1744-9987.13647. Epub 2021 Apr 12. Ther Apher Dial. 2022. PMID: 33763913
-
Cerebral computed tomography in uremic and hemodialyzed patients.J Comput Assist Tomogr. 1986 Jul-Aug;10(4):567-70. doi: 10.1097/00004728-198607000-00003. J Comput Assist Tomogr. 1986. PMID: 3734196
-
Hypertension in chronic renal failure. Treatment with hemodialysis and nephrectomy.Arch Intern Med. 1974 Jun;133(6):1059-66. Arch Intern Med. 1974. PMID: 4597951 Review. No abstract available.
Cited by
-
Intradialytic hypotension and relationship with cognitive function and brain morphometry.Clin Kidney J. 2020 Dec 5;14(4):1156-1164. doi: 10.1093/ckj/sfaa070. eCollection 2021 Apr. Clin Kidney J. 2020. PMID: 33841861 Free PMC article.
-
Cerebral metabolic changes in neurologically presymptomatic patients undergoing haemodialysis: in vivo proton MR spectroscopic findings.Eur Radiol. 2010 Jun;20(6):1502-7. doi: 10.1007/s00330-009-1673-2. Epub 2009 Dec 8. Eur Radiol. 2010. PMID: 19997847
-
Cognitive interventions for adults with chronic kidney disease: protocol for a scoping review.Syst Rev. 2020 Mar 17;9(1):58. doi: 10.1186/s13643-020-01320-x. Syst Rev. 2020. PMID: 32183894 Free PMC article.
-
Ectopic ossification in the cranial dura mater in dialysis patients with secondary hyperparathyroidism.NDT Plus. 2010 Feb;3(1):64-7. doi: 10.1093/ndtplus/sfp115. Epub 2009 Sep 9. NDT Plus. 2010. PMID: 25949408 Free PMC article.
-
Brain calcinosis in a dialysis patient with hypoparathyroidism.NDT Plus. 2008 Feb;1(1):36-40. doi: 10.1093/ndtplus/sfm025. Epub 2007 Dec 24. NDT Plus. 2008. PMID: 30792783 Free PMC article. No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical